Jove
Visualize
Contact Us

Related Concept Videos

Acne Infection01:27

Acne Infection

48
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
48
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.1K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.1K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinico-Dermoscopic Report of Jellyfish Dermatitis ( Lobonemoides Robustus )-Two Cases in the Same Family.

Indian dermatology online journal·2026
Same author

Ultraviolet-induced fluorescence dermoscopy of scabies mite-gallery unit: three patients in the same family.

Clinical and experimental dermatology·2025
Same author

Dermoscopy and Ultraviolet Reflectance Dermoscopy of Benign Lichenoid Keratosis Masquerading as Melanoma.

Indian dermatology online journal·2025
Same author

Clinico-Dermoscopic Report of Molluscum Dermatitis: A Pearly Puzzle in Focus.

Cureus·2025
Same author

Pustular and crusted lesions in systemic lupus erythematosus: A case report.

Journal of family medicine and primary care·2024
Same author

Deep Dermal Dilemma: A Case Report on Majocchi's Granuloma After Topical Steroid Use.

Cureus·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 30, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.4K

Decrease in "Hamilton Rating Scale for Depression" Following Isotretinoin Therapy in Acne: An Open-Label Prospective

Pushpa Gnanaraj1, Subashini Karthikeyan1, Murali Narasimhan1

  • 1Department of Dermatology, SRM Medical College Hospital and Research Centre, Kattankulathur, Kancheepuram, Tamil Nadu, India.

Indian Journal of Dermatology
|November 6, 2015
PubMed
Summary

This study found that oral isotretinoin effectively treats moderate to severe acne and significantly reduces depression scores. The treatment was not associated with an increased risk of depression or suicidal tendencies in patients.

Keywords:
Acnedepressionisotretinoin

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

816

Related Experiment Videos

Last Updated: Mar 30, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.4K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

816

Area of Science:

  • Dermatology
  • Psychiatry

Background:

  • Acne vulgaris affects many adolescents and young adults, often leading to psychological distress such as anxiety and depression.
  • Oral isotretinoin is a highly effective treatment for moderate to severe acne.
  • Concerns exist regarding a potential link between isotretinoin and depression, but evidence remains inconclusive.

Purpose of the Study:

  • To investigate the association between oral isotretinoin treatment and the risk of developing depression in patients with moderate to severe acne.
  • To evaluate the impact of oral isotretinoin on acne severity and psychological well-being.

Main Methods:

  • A cohort of 150 patients with moderate to severe acne received oral isotretinoin (0.5 mg/kg/day) for three months.
  • Acne severity and depression scores were assessed at baseline, monthly during treatment, and at a six-month follow-up.

Main Results:

  • Oral isotretinoin treatment led to a significant reduction in acne severity (P < 0.001).
  • A significant decrease in depression scores was observed during the treatment period (P < 0.001).
  • Both acne and depression scores remained significantly low at the six-month follow-up.

Conclusions:

  • Oral isotretinoin effectively clears acne lesions.
  • The treatment is associated with a significant reduction in depression scores.
  • This study did not find evidence linking oral isotretinoin to an increased incidence of depression or suicidal tendencies.